Mörk Anna-Karin, Jonsson Fredrik, Johanson Gunnar
Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Pharsight, a Certara™ Company, St. Louis, MO, USA.
Regul Toxicol Pharmacol. 2014 Jun;69(1):78-90. doi: 10.1016/j.yrtph.2014.02.015. Epub 2014 Mar 6.
The availability of experimental data suitable as a basis to quantify human variability in response to chemical exposure has increased in recent years. It has enabled scientifically based, data driven adjustment factors (AF) to be deployed in the risk assessment process. As part of this development, we derive AF for human toxicokinetic variability (HK) for three lipophilic organic solvents; toluene, styrene and methyl chloride using physiologically based pharmacokinetic (PBPK) models in a population framework. The Monte Carlo simulations cover the influence of age and gender on toxicokinetic variability in the general population, as well as workplace ventilation rates and fluctuations in exposure level and workload in adult male and female workers. The derived AFHK are below 2.2 (95th percentile) for all subpopulations, exposure scenarios and chemicals, except for markers of acute effects in workers, where the factors are up to 5.0.
近年来,可作为量化人类对化学物质暴露反应变异性基础的实验数据有所增加。这使得在风险评估过程中能够采用基于科学、数据驱动的调整因子(AF)。作为这一发展的一部分,我们使用群体框架下的生理药代动力学(PBPK)模型,推导了三种亲脂性有机溶剂(甲苯、苯乙烯和氯甲烷)的人体毒代动力学变异性(HK)的AF。蒙特卡罗模拟涵盖了年龄和性别对普通人群毒代动力学变异性的影响,以及成年男性和女性工人的工作场所通风率、暴露水平波动和工作量。除工人急性效应标志物的因子高达5.0外,所有亚人群、暴露场景和化学物质的推导AFHK均低于2.2(第95百分位数)。